Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

What’s Happening with the Mifepristone Federal Court Case?

We expect the ruling in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration to be issued as soon as February 24 (this is a change from the February 10 date that was as previously shared). The judge in the case recently issued an order giving the plaintiffs two more weeks to file a response to briefs previously filed by the Department of Justice and Danco.


A group of anti-abortion activists and organizations sued the U.S. Food and Drug Administration (FDA) in federal court in Amarillo, Texas over the FDA’s approval of mifepristone (mife), one of two medications most commonly used in medication abortion in the United States. In the Texas case, Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al, the plaintiffs have asked the court to issue a preliminary injunction ordering the FDA to withdraw or suspend its approval of mifepristone in 2000, and subsequent FDA decisions making changes to the risk evaluation and mitigation strategy (REMS) for mife (including in 2016 and 2021). The decision on this motion could result in a nationwide ban on mifepristone — even in states where abortion is protected. PPCWNY has plans in place to shift to a misoprostol (miso) only regimen if it becomes against the law to use mife. This is a safe and effective way to provide medication abortion and is used in many places.

Please note: Planned Parenthood is not part of this litigation — the case was brought against the FDA (and the manufacturer of Mifeprex, Danco, has sought to intervene as well).


This website uses cookies

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.



We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.



We use qualitative data, including session replay, to learn about your user experience and improve our products and services.



We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.